Skip to main content

Month: January 2026

Telenor sells ownership in True Corporation

CEOs of Telenor & AriseKhun Suphachai Chearavanont, owner of Arise & Benedicte Schilbred Fasmer, CEO Telenor GroupFornebu, Norway – January 22, 2026 – After 25 successful years in Thailand, Telenor has agreed to sell its stake in True Corporation for a total value of approximately NOK 39 billion. Telenor Group has signed an agreement with Arise Digital Technology Company Limited, a company owned by Khun Suphachai Chearavanont, to sell 24.95 percent of the shares in True at THB 11.70 per share. In addition, Arise and Telenor have agreed a mutual put/call option for the sale of the remaining 5.35 percent two years after closing of the initial sale at the higher of THB 11.70 per share and the market price prior to the term of the option. “We are pleased to have reached an agreement with Arise about the sale of our stake...

Continue reading

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) — Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced the pricing of an upsized underwritten public offering of 4,000,000 shares of its common stock at a price to the public of $31.00 per share, before underwriting discounts and commissions. All of the shares to be sold in the proposed offering are to be sold by Axogen. In addition, Axogen has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds to Axogen from the proposed offering, before deducting underwriters’ discounts and commissions and other offering...

Continue reading

Corvus Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced the pricing of an upsized underwritten public offering of 7,900,677 shares of its common stock at a price to the public of $22.15 per share. Gross proceeds from the underwritten public offering before deducting underwriting discounts and commissions and estimated offering expenses are expected to be approximately $175.0 million. All of the shares of common stock are being offered by Corvus. In addition, Corvus has granted the underwriters of the offering a 30-day option to purchase up to an additional 1,185,101 shares of common stock at the public offering price, less underwriting discounts and commissions. Corvus currently expects to use the net proceeds from this...

Continue reading

BioAge Announces Pricing of Upsized $115.0 Million Public Offering

EMERYVILLE, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) — BioAge Labs, Inc. (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced the pricing of its upsized underwritten public offering of 5,897,435 shares of its common stock at a price to the public of $19.50 per share. The gross proceeds from this offering are expected to be approximately $115.0 million, before deducting underwriting discounts and commissions and other offering expenses payable by BioAge. The offering is expected to close on or about January 23, 2026, subject to the satisfaction of customary closing conditions. In addition, BioAge has granted the underwriters a 30-day option to purchase up to an additional...

Continue reading

NUNC Capital joins high tech start-up AnGard Microwave to strengthen Europe’s High-Power Microwave capability

AMSTERDAM, Jan. 22, 2026 (GLOBE NEWSWIRE) — NUNC Capital has acquired a strategic minority stake in AnGard Microwave as part of the company’s seed round, supporting its next phase of growth and development. This investment brings NUNC alongside AnGard’s founding team, as well as existing shareholders TNO and the University of Twente. With this investment, NUNC joins a strong Dutch research and defense innovation ecosystem to accelerate the development and deployment of High-Power Microwave technology for defense applications. AnGard develops directed energy High-Power Microwave counter-robotic systems designed to neutralize a wide range of autonomous and robotic threats. Its technologies are built to disrupt, disable, or degrade electronic systems without physical interception, making them applicable across both defense and security...

Continue reading

Erasca Announces Pricing of Upsized Public Offering of Common Stock

SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of an upsized public offering of 22,500,000 shares of its common stock. The shares of common stock are being sold to the public at a price of $10.00 per share. All of the shares of common stock to be sold in the public offering are to be sold by Erasca. The gross proceeds to Erasca from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be $225.0 million. In addition, Erasca has granted the underwriters a 30-day option to purchase up to an additional 3,375,000 shares of common stock at the offering...

Continue reading

Reflex Advanced Announces Private Placement Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 21, 2026 (GLOBE NEWSWIRE) — Reflex Advanced Materials Corp. (CSE:RFLX) (FSE:HF2) (“Reflex” or the “Company”), is pleased to announce that it intends to complete a non-brokered private placement offering of units of the Company (“Units”), at a price of C$0.175 per Unit, for aggregate gross proceeds of up to C$200,000. Each Unit will be comprised of one common share of the Company (each, a “Share”) and one Share purchase warrant (“Warrants”), with each Warrant entitling the holder to acquire one Share (each, a “Warrant Share”) at a price of C$0.23 for a period of 24 months. The Company intends to use the net proceeds raised from the Offering for working capital and general corporate purposes. All securities...

Continue reading

Telesat Statement on Creditor Litigation

OTTAWA, Ontario, Jan. 21, 2026 (GLOBE NEWSWIRE) — Telesat (Nasdaq and TSX: TSAT), one of the world’s largest and most innovative satellite operators, confirms that certain creditors holding portions of the company’s legacy GEO (Geostationary Earth Orbit) debt have filed lawsuits in both New York and Ontario regarding the equity distribution in September 2025 of the Telesat Lightspeed business. The lawsuits, filed at the direction of a group of distressed debt hedge funds, are without merit. The equity distribution at issue followed a robust governance process and was accomplished in strict accordance with relevant debt agreements and applicable law. Telesat intends to defend itself vigorously. Telesat and its stakeholders are firmly committed to supporting the company’s customers, advancing the Telesat Lightspeed program, and creating...

Continue reading

Rocket Lab Neutron Test Update

LONG BEACH, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced an update relating to the development of its Neutron rocket. As the Company pushes Neutron to the limits and beyond to qualify its systems and structures for launch, qualification testing of the Stage 1 tank overnight resulted in a rupture during a hydrostatic pressure trial. Testing failures are not uncommon during qualification testing. We intentionally test structures to their limits to validate structural integrity and safety margins to ensure the robust requirements for a successful launch can be comfortably met. There was no significant damage to the test structure or facilities, the next Stage 1 tank is already in production, and...

Continue reading

Crown Castle Announces Tax Reporting Information for 2025 Distributions

HOUSTON, Jan. 21, 2026 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) announced today certain year-end tax reporting information for its 2025 distributions. The following table summarizes, for income tax purposes, the nature of distributions paid to holders of Crown Castle Common Stock, par value $.01 per share (“Common Stock”), presented on a per share basis, during the calendar year ended December 31, 2025. Stockholders are urged to consult with their personal tax advisors as to their specific tax treatment of Crown Castle’s distributions. Crown Castle Common StockTicker Symbol: CCICUSIP 22822V101Record Date Payment Date Cash Distribution (per share) Ordinary TaxableDividend(per share) Qualified Taxable Dividend(per share)* Section 199A Dividend(per share)* Non-Taxable Distribution (per share)3/14/2025 3/31/2025 $1.565000 $1.292363 $0.029189 $1.263174 $0.2726376/13/2025 6/30/2025 $1.062500 $0.877403 $0.019817 $0.857586 $0.1850979/15/2025 9/30/2025 $1.062500 $0.877403 $0.019817 $0.857586 $0.18509712/15/2025 12/31/2025 $1.062500 $0.877403 $0.019817 $0.857586 $0.185097*Qualified...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.